3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Conditions
Carcinoma, Medullary
2
Aggression
1
Interventions
vandetanib
1
Positron Emission Tomography Computed Tomography
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Aggression
×
vandetanib
×
Clear all
NCT01945762
2024-12-18
Caprelsa104
Sanofi
Completed
31 enrolled